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Gene expressionBackground and purpose: Non-homologous end joining (NHEJ) is the major pathway for removing DNA
double strand breaks lesions. NHEJ is considered to be a resistant factor against chemotherapy induced
neuropathy. b-Lapachone (b-Lap) is one of the antineoplastic agents which is shown to have anti neuroin-
flammatory effects. Extremely low frequency (<300 Hz) electromagnetic field (EMF) is shown to decrease
NHEJ genes expression. Morphine (Mor) is associated with reducing effect on DNA repair and induce DNA
damages. The goal of this study was to evaluate the effect of combination treatment of b-Lap, morphine
(Mor) and EMF on expression of NHEJ related genes (XRCC4, Ku70, Ku80, DNA-PKcs and LIG4).
Materials and methods: SH-SY5Y cells (epithelial neuroblasts) were treated with four combinational treat-
ments of b-Lap (2.0 and 3.2 lM), Mor (5.0 lM) and EMF (50 Hz, 0.50 mT, ‘‘15 min field on/15 min field
off”) and mRNA levels of XRCC4, Ku70, Ku80, DNA-PKcs and LIG4 were evaluated by quantitative real-
time PCR and primers specific for the examined genes. The experiments were done in triplicates.
Results: No significant alteration in the mRNA levels of NHEJ related genes was observed in ‘‘b-Lap alone”
and ‘‘b-Lap + Mor” treated cells. The expression levels of NHEJ related genes were significantly increased
in ‘‘b-Lap + EMF” and ‘‘b-Lap + Mor + EMF”. Multiple linear regression analysis showed that the effect of
EMF and Mor on NHEJ related genes expression is opposite to the effect of b-Lap.
Conclusion: In overall, combination of b-Lap, Mor and EMF leads to increased expression of NHEJ related
gene expression. This effect may lead to decreased sensitivity of SH-SY5Y cells against b-Lap and can
improve its neuroprotective property which might be hopeful for its clinical applications.
 2017 Ain Shams University. Production and hosting by Elsevier B.V. This is an open access article under
the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
b-Lapachone (b-Lap), is a natural naphthoquinone anticancer
drug which is activated by NAD(P)H quinone oxidoreductase 1
(NQO1) and generates hydroquinone and ROS [1]. b-Lap has
several special characteristics such as anti-neoplastic and anti-
neuroinflamatory [2] properties to which much attention has
focused. Different studies have shown that b-Lap exerts cytotoxic
effect via its inhibitory effect on topoisomerase I and induction of
ROS generation which ultimately leads to DNA double strand
breaks [3,4]. Non-homologous end joining (NHEJ) is themajor path-
way for removing DNA double strand breaks lesions around the cell
cycle and is known to be responsible for repair of nearly 80% of dou-
ble strand breaks [5]. The most important components involved inNHEJ pathway include DNA-PKcs (OMIM: 600899), Ku70 (OMIM:
152690), Ku80 (OMIM: 194364), LIG4 (OMIM: 601837), and XRCC4
(OMIM: 194363). There are evidences which indicate that b-Lap
efficiency can be affected by NHEJ performance [6].
Extremely low frequency (<300 Hz) electromagnetic field (EMF)
was shown to decrease NHEJ genes expression [7]. Morphine (Mor)
is also reported to have reducing effect on DNA repair [8], induce
DNA damages [9], and down-regulate several antioxidant genes
[10,11]. Different studies have shown that changes in DNA repair
capacity is the cornerstone in defining cell response to DNA dam-
aging drugs such as b-Lap [12]. On the other hand DNA repair
can play pivotal role for protecting against chemotherapy induced
neuropathies [13]. To our knowledge there is no study on the effect
of combination treatment of b-Lap, Mor, and EMF on the transcript
levels of NHEJ related genes. This study was conducted to investi-
gate the expression levels of NHEJ related genes in human SH-SY5Y
cells under treatments of ‘‘b-Lap alone”, ‘‘b-Lap + Mor”, ‘‘b-Lap
+ EMF” and ‘‘b-Lap + Mor + EMF”. SH-SY5Y cell line corresponds
to epithelial neuroblasts which are known as an experimental cell
models for in vitro studies of neural functions.
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2.1. Cell culture
SH-SY5Y neuroblastoma cell line was obtained from Pasteur
Institute of Iran and cultured in DMEM/F12 enriched with 10%
FBS (Gibco), penicillin (100 U/ml, Sigma) and streptomycin
(100 lg/ml, Sigma). Cultures were maintained in a 37 C incubator
with a 5% CO2, 95% air atmosphere.
2.2. EMF exposure
The exposure apparatus was consisted of a solenoid working
with 50-Hz sinusoidal alternating current to generate 0.50 mT
EMF in the intermittent pattern of ‘‘15 min field on/15 min field
off” [14]. The total time for EMF exposure was 30 min. No temper-
ature change was observed during EMF exposure.
2.3. Treatments
Four treatments were applied in this study as followed: 1) b-Lap
alone; 2) ‘‘b-Lap + Mor”; 3) ‘‘b-Lap + EMF”; 4) ‘‘b-Lap + Mor + EMF”.
Two concentrations of b-Lap (2.0 and 3.2 lM, Sigma-Aldrich) and aFig. 1. mRNA levels of the examined genes of non-homologous end joining pathway in
+ Mor + EMF” treated cells. (EMF: electromagnetic field, Mor: morphine, 5.0 lM). n = 3, m
hoc test.single dose of Mor (5.0 lM, LGS standards, Swiss) were used in this
experiment. SH-SY5Y cells were seeded at 3  105 cells/ml and
incubated at 37 C for 24 h. For ‘‘b-Lap + EMF” treatment, the cells
were treated with b-Lap and subsequently exposed to EMF. For ‘‘b-
Lap + Mor + EMF” treatment, cells were treated with b-Lap andMor
and then exposed to EMF. Cells which were treated with ‘‘b-Lap
alone” or ‘‘b-Lap + Mor”, were located in the EMF apparatus, for
the same time when the power was off. In all treatments, cells
were harvested after 24 h and then RNA extraction was done.
2.4. RNA extraction, cDNA synthesis and real time PCR
RNA extraction, cDNA synthesis, quantitative real-time PCR and
primers specific for the examined genes were described before [7].
Quantitative real time PCR analysis was carried out using syber
premix Ex TaqTM II (Takara Bio Inc., Japan) in Rotor-Gene 6000
instrument (Corbett research). Relative gene expression was ana-
lyzed using 2DDCt method [15].
2.5. Statistical analysis
The experiments were done in triplicates. Data were shown as
means ± standard error (SE). Alterations in mRNA levels were‘‘b-Lap” (b-Lapachone, at 2.0 and 3.2 lM), ‘‘b-Lap + Mor”, ‘‘b-Lap + EMF” and ‘‘b-Lap
ean ± SE. *P < 0.05 all values compared with control cultures using Bonferroni post
Table 1
Results of multiple linear regression analysis of non-homologous end joining related
transcript levels in human SH-SY5Y cells when the cells were exposed to combination
treatment of b-Lap (b-Lapachone, at 2.0 and 3.2 lM), EMF (electromagnetic fields),
and Mor (morphine, 5.0 lM). The treatments are mentioned in the text.
XRCC4
b* t P
b-Lap 0.056 0.70 0.491
Mor 0.076 0.97 0.339
EMF 0.937 12.0 <0.001
Adjusted R2 = 0.854; F = 51.6; df = 3, 23; P < 0.001
Ku80
b* t P
b-Lap 0.099 0.74 0.462
Mor 0.068 0.52 0.605
EMF 0.778 6.04 <0.001
Adjusted R2 = 0.599; F = 13.9; df = 3, 23; P < 0.001
Ku70
b* t P
b-Lap 0.423 2.77 0.011
Mor 0.029 0.19 0.844
EMF 0.500 3.38 0.003
Adjusted R2 = 0.470; F = 8.6; df = 3, 23; P < 0.001
DNA-PKcs
b* t P
b-Lap 0.327 3.53 0.002
Mor 0.238 2.65 0.014
EMF 0.903 10.0 <0.001
Adjusted R2 = 0.805; F = 36.6; df = 3, 23; P < 0.001
LIG4
b* t P
b-Lap 0.146 1.99 0.058
Mor 0.055 0.76 0.450
EMF 0.967 13.6 <0.001
Adjusted R2 = 0.878; F = 64; df = 3, 23; P < 0.001
* Standardized coefficient.
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Bonferroni post hoc test. A multiple linear regression analysis
was conducted to determine the effect of b-Lap, Mor and EMF on
the expression levels of NHEJ related genes. Statistical analysis
was done using SPSS statistical software package (v. 20, SPSS Inc.
Chicago, IL, USA). A probability of P < 0.05 was considered statisti-
cally significant.
3. Result
The relative IC50 value of b-Lap was estimated 3.54 (95% CI:
3.45–3.63) lM. In the present study we used b-Lap at two final
concentrations: 2.0 and 3.2 lM. It should be noted that 3.2 lM b-
Lap showed about 18 percent cytotoxicity, whereas 2.0 lM b-Lap
showed no cytotoxicity.
Fig. 1 shows the alteration of mRNA levels of NHEJ related genes
in ‘‘b-Lap alone”, ‘‘b-Lap + Mor”, ‘‘b-Lap + EMF” and ‘‘b-Lap + Mor
+ EMF” treatments. No significant alteration in the mRNA levels
of NHEJ related genes was observed in ‘‘b-Lap alone” and ‘‘b-Lap
+ Mor” treated cells. The mRNA levels of NHEJ related genes were
significantly increased in ‘‘b-Lap + EMF” and ‘‘b-Lap + Mor + EMF”.
XRCC4, Ku80, DNA-PKcs and LIG4were the most up-regulated genes
in 2.0 and 3.2 lM b-Lap combined with EMF or ‘‘Mor + EMF”. Ku70
was the only gene whose expression was not increased and in fact
it was decreased when EMF was applied in combination with
3.2 lM b-Lap (Fig. 1).
Multiple linear regression analysis showed that EMF was posi-
tively associated with the expression levels of XRCC4, Ku80, DNA-
PKcs and LIG4 and negatively associated with the Ku70 expression
level. Mor had positive effect on DNA-PKcs transcript level. Itshould be noted that concentration of b-Lap had negative effect
on the mRNA levels of Ku70 and DNA-PKcs (Table 1).4. Discussion
At present time, Mor is widely administered for pain relief in
cancer patients receiving chemotherapy [16,17]. Studies have
shown that Mor might be associated with oxidative stress and
DNA damage [9,18–20]. Extremely low frequency electromagnetic
field (EMF) is a non-ionizing and non-thermal power which can
penetrate the cell and affect many cellular functions including
alterations in expressional levels target genes [21]. We showed
that the 50 Hz EMF (0.50 mT, ‘‘15 min field on/15 min field off”)
can modulate the mRNA levels of genes related to DNA repair
pathways and subsequently alter cellular toxicity to cisplatin, an
alkylating agent [7]. Today chemotherapy drugs and Mor are
simultaneously used [22] and peripheral neuropathy is one of the
important side effects of chemotherapy regiments [23]. Consider-
ing that alterations in NHEJ is associated with the efficiency of
treatment [12,24–26] and there is no published study on the effect
of combination treatment of b-Lap, Mor and EMF on transcript
level of NHEJ related genes, the present experiments were carried
out.
Although treatment with each of extremely-low frequency of
EMF [6] and Mor [7] has been reported to reduce transcript level
of NHEJ genes, our present results showed that EMF was associated
with increasing the mRNA levels of NHEJ related genes (Table 1). It
might be concluded that the effect of EMF (and also Mor) on the
expression of NHEJ related genes is opposite to the effect of
b-Lap. Hence combination of b-Lap, Mor and EMF leads to
increased expression levels of the examined NHEJ related genes.
This elevation may lead to increased repair of double strand
breaks. Recently it has been shown that inhibition of NHEJ could
strengthen b-Lap lethality [5]. There are some reports which indi-
cate that b-Lap has a preventive neuroinflammatory property
which is hopeful for eliminating neural degeneration during
treatments [2]. Since SH-SY5Y is a suitable model for studying
chemotherapy-induced neuropathies, our data suggest that the
empowered capacity of DNA repair of double strand breaks may
lead to decreased sensitivity of SH-SY5Y cells and improve the
neuroprotective properties of b-Lap in combination with EMF.5. Conclusion
In this study SH-SY5Y cells were applied as an in vitro model for
studying chemotherapy-induced neuropathies. According to the
presented results, combination treatment of b-Lapachone, mor-
phine and extremely low frequency (50-Hz) electromagnetic field
leads to increased expression of non-homologous end joining
(NHEJ) related genes. Considering the important role of DNA repair
capacity for protecting against neural degeneration, it is suggested
that extremely low frequency electromagnetic field treatment can
improve the neuroprotective properties of b-Lapachone in SH-SY5Y
cells. Further in vivo experiments should be conducted to confirm
our present results.Disclosure statement
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